A.R.T. Advisors’s CONMED CNMD Stock Holding History

A.R.T. Advisors’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-9,847	Closed	-$1.1M	–	243
2019 Q4	$1.1M	Buy	+9,847	New	+$1.05M	0.05%	512
2018 Q4	–	Sell	-5,745	Closed	-$455K	–	1360
2018 Q3	$455K	Buy	5,745 +2,600	+83%	+$201K	0.02%	894
2018 Q2	$230K	Sell	3,145 -3,800	-55%	-$258K	0.01%	1190
2018 Q1	$439K	Buy	+6,945	New	+$415K	0.02%	1009
2015 Q1	–	Sell	-5,085	Closed	-$228K	–	1459
2014 Q4	$228K	Buy	+5,085	New	+$213K	0.01%	1193
2014 Q3	–	Sell	-12,540	Closed	-$553K	–	1334
2014 Q2	$553K	Buy	+12,540	New	+$569K	0.03%	733

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

A.R.T. Advisors's CNMD Position: Q1 2020 in Review

A.R.T. Advisors sold out of CONMED (CNMD) in Q1 2020, closing a stake of 9,847 shares — an estimated $1.1M sold.

A.R.T. Advisors first reported a position in CNMD in Q2 2014 and held it in 6 quarters. The position peaked at $1.1M in Q4 2019. 228 funds tracked by Wall St. Rank hold CNMD as of Q1 2020.

A.R.T. Advisors reported no remaining CONMED position as of Q1 2020 after selling out during the quarter.
A.R.T. Advisors sold 9,847 CONMED shares in Q1 2020, an estimated $1.1M.
A.R.T. Advisors first reported a position in CONMED in Q2 2014 and held it in 6 quarters.
A.R.T. Advisors's CONMED position peaked at $1.1M in Q4 2019.
228 funds tracked by Wall St. Rank held CONMED as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.